New Year, New You!


So, I have conversations about diet, exercise and weight loss every day in my practice. But it seems that sometime around Jan 1, those conversations are more often started by my patients.  We are moving from the indulgent end of the year holiday season, to the fresh start of a new year.  So it seems natural to try to start fresh- live healthier, better, richer…

Well, maybe not richer. But there are a lot of people getting richer of our desires to look and feel healthier. So there are a lot of theories about how we got her, and promises to do this one thing, cut out this, take this pill, and turn your life around. Face it, a quick fix seems pretty damn appealing to all of us.  And I am in the pill pushing business. A big part of my job is to prescribe medicines.  So with all of these conversations about losing weight, medicine is a frequent question.


So today, I’m going to build on a recent morning report lecture on obesity to focus on medical treatments for obesity.  We’ll talk about old, new, tried and true and up and coming.  I’ll try to highlight the evidence base for these so that you can discuss in an informed way with your patients.

I also want to start with a disclosure.. I almost never prescribe medicine for weight loss. My bias (and I’ll argue, the evidence) is that these are generally not that helpful, and almost always patients gain back weight, plus more, once they stop taking them.  The studies that got these medicines approved were always coupled with a solid diet and exercise plan, and I think that most of the weight loss comes from that activity, NOT from the medicine.


Orlistat inhibits pancreatic lipases, so less fat is absorbed in digestion. In studies, patients on orlistat lost 5-10kg (compared to 3-6kg with diet/exercise alone). It also has been shown to lower blood pressure, and LDL levels more than would be expected by the weight loss alone.  It is safe, as most of it remains un-absorbed. However, the main side effects are GI related: bloating, nausea, and diarrhea. These are generally pretty limiting, and I haven’t found many patients willing to even try orlistat after hearing these effects. However, if patients can stick to a low-fat diet, the effects can be minimized.



Phentermine is a stimulant that suppresses appetite. It is the oldest of the approved medicines for weight loss, and also one of the cheapest. It is approved for 12 weeks of therapy, so most studies are of short duration only.  Studies show around 7kg of weight loss. Side effects include hypertension, tachycardia, anxiety, insomnia- in my experience these are pretty limiting.

There is a new medicine that combines phentermine with topiramate, Qsymia. The phentermine dose is lower than if prescribed separately, and it is approved for longer term use.  The initial trial for this Rx showed patients lost 8-10 kg in the first year, and could maintain weight loss if they continued for another year. Only about 60% of patients took the Rx for the whole first year.


So what about just Topiramate itself? Currently topiramate is approved for treatment of epilepsy and migraine. Using it for weight loss is off label- so beware. However, it has been studied, and patients lost about 4kg over 6 months in the various trials.


Lorcaserin (Belviq) is a serotonin receptor agonist, and thus serves as an appetite suppressant. A few other serotonin agonists have been tried over the years- fenfluramine- and lead to cardiac valve disease. Lorcaserin is more specific to the 2C receptor, which should minimize cardiovascular effect. In trials, more patients on lorcaserin lost at least 5% of their body weight (mean 5kg). There were also decreases in BP, HR, LDL, CRP, and glucose. All of the trials had dropout rates close to 50%.  Side effects include headache, nausea, URI sx, and back pain.


Diabetes Drugs: 

Liraglutide (Victoza, Saxenda- same Rx, two brand names) is the one drug in this group with an indication for weight loss. In patients without diabetes, trials showed around 7kg of weight loss, and in one trial, patients who lost weight pre medicine were more likely to maintain the weight loss if on liraglutide. Side effects include diabetesnausea/vomiting/diarrhea and rarely, pancreatitis.

Metformin Old drug, lots of data on weight loss, but still no indication for obesity treatment. Why? Patients don’t tend to lose a lot of weight with metformin- about 2kg.  But what different with metformin, is that there is long-term data that showed that patients could maintain that weight loss as long as they stayed on the Rx.  And it decreases incidence of diabetes in these people as well. Certainly something to consider in obese patients with pre-diabetes or otherwise at high risk.


Another off label use here, but post marking data did show a tendency toward weight loss in patients on bupropion. Remember, this drug increases norepinephrine effect, so likely has some sympathomimetic benefits. In one short (6 month) trial, patients on bupropion lost 7-10% of their body weight (compared to 5% lost on placebo).

There is a brand new combo drug that uses Naltrexone and Bupropion (Contrave). Patients got about 5% weight loss over a longer study (56 weeks), but only about half of the patients were able to complete the study. Nausea, headache, and constipation were common side effects. There is also a cardiovascular concern that is being actively monitored in the post-marketing period.


Big Picture

Diet and exercise are the key- slow and steady wins the race. There may be some small incremental gains with the medicines above, but I think that the evidence is thin, there are clear side effects, and the risks are not always understood. Given the millions of Americans that could end up on these medicines, I’d prefer to hang back and wait for the fallout before becoming an early prescriber of any of these.




We had a great #proudtobeGIM lunch at UASOM yesterday, with an amazing panel of diverse general internists, a room full of interested and engaged students, and free lunch! As I reflect on the career journeys of my colleagues, I was struck by my own path.

Once I figured out medical school was the right direction for me, it was always primary care.  Joel Fleischman, perhaps more than any other fictional character, was always my inspiration.  Well trained, bright, and then immersed in a community, perhaps a small one, where you get to know EVERYONE. Take care of whole families, and see your patients at the grocery store.maxresdefault

Over the course of medical school, “primary care” became General Internal Medicine.  I picked medicine over family practice because I really enjoyed the complexity of adult patients with multiple chronic diseases, and saw that I could have a real impact in that group of people. It has given me the long-term relationships that I craved early on. And I  still get to treat families.  I have often been “auditioned” by the mom, who then refers her adult children, husband, sister, neighbor….  It is quite an honor when I pass muster.  And I see my patients at the grocery store, park, and most frequently when I’m sitting down to a cheeseburger, fries, and a milkshake. Doctors, they’re just like us!


What took my by surprise was my love for teaching. Once I became a ward resident, I realized that breaking complex topics down to explain to others was a lot like giving advice to patients, and sometimes even more fun. Not only did I learn things more deeply after teaching them, I got to forge these great relationships with my colleagues. But primary care was still my goal. I wasn’t going to do a fellowship, and I wasn’t a chief resident, so I didn’t think academic medicine would be in the cards for me. Until a mentor approached me about interviewing for a position in GIM. I think that I actually said, “Really? Y’all would hire me?!

I interviewed for private practice groups and for GIM at UAB, and it became clear that I was much more excited about teaching and administration than I ever would have thought during my preclinical years.  Everyone I work with does something different, which really gives me a feeling that the sky is the limit. Certainly I have to earn my salary, but I can take my career in so many directions.  I have opportunities to get more training in education, QI, research techniques, leadership, and more.  And the “earning my salary” part- seeing patients and teaching residents in clinic, is pretty great. I love my job now, and I love the possibilities for the future.

All of this makes me incredibly Proud to be GIM!


SGIM Proud to be GIM website

Follow us on Facebook and Twitter  @UABGIM

Join us at Cantina Tortilla Grill (Pepper Place) on Jan 18th @ 5:30 for Food, drink, and more great insights on GIM as a career path.